Tim McCarthy

Tim McCarthy is the CEO at ImmuPharma. Prior to this, they were with Peptide Therapeutics plc where they served as Co-Founder and Finance Director. Peptide Therapeutics was a biopharmaceutical company that was formed in 1993 with a focus on discovering and developing drugs in the area of inflammation and vaccines. The company was listed on the London Stock Exchange in 1995 and later acquired Oravax in the USA. In 2008, the company was sold to sanofi-aventis for £276 million.

After graduating from college, Tim McCarthy pursued a Master of Business Administration (MBA) at Cranfield School of Management. Tim then went on to get their FCCA from the Chartered Association of Certified Accountants.